You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

SAFETY OF MEFLOQUINE IN INFANTS WITH ACUTE FALCIPARUM MALARIA

Dubos, François MD†; Delattre, Pierre MD†; Demar, Magali MD‡; Carme, Bernard MD‡; Gendrel, Dominique MD§

Pediatric Infectious Disease Journal:
Brief Reports
Abstract

We evaluated retrospectively the safety of mefloquine (25 mg/kg) for the curative treatment of uncomplicated Plasmodium falciparum malaria in 26 infants weighing <15 kg and managed during a 5-year period. Side effects were recorded in 30.8% of patients and consisted chiefly of mild and transient gastrointestinal symptoms. Mefloquine was safe in infants weighing <15 kg in our experience.

Author Information

From the Pediatric Intensive Care Unit, Jeanne de Flandre Hospital, Lille, France; the †Pediatrics Department, Andrée Rosemon Hospital, Cayenne, France; the ‡Parasitology-Mycology Laboratory, Cayenne Teaching Hospital and Antilles Guyana Teaching and Research Center, Cayenne, France; and the §Pediatrics Department, Saint Vincent de Paul Teaching Hospital, Paris, France

Accepted for publication February 13, 2004.

Address for reprints: Francçois Dubos, MD, Service de Réanimation Pédiatrique, Hôpital Jeanne de Flandre, 2 avenue Oscar Lambret, 59 037 Lille Cedex, France. Fax +33 3 20 44 60 83; E-mail frandubos@wanadoo.fr

© 2004 Lippincott Williams & Wilkins, Inc.